MONKEYPOX EXPLAINER
Monkeypox outbreak - an Imperial expert explains
The UK Health Security Agency is investigating four new cases of monkeypox in the UK. There are now a total of six confirmed cases.
Stories tagged with 'viruses'
News in brief
Arctic clouds and harnessing light: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
Feature
HEPATITIS OUTBREAK
Hepatitis outbreak in children: What do we know so far?
Scientists and healthcare professionals around the world are continuing to investigate a sudden increase in hepatitis cases in children.
1
Medical science awards
Six Imperial researchers awarded AMS Fellowships
Six Imperial researchers have been elected to the Fellowship of the Academy of Medical Sciences for their outstanding work in their fields.
News in brief
Imperial reactor delicensed and viral variants: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
COVID and flu
COVID-19 mixed with flu increases risk of severe illness and death
Patients in hospital with both COVID-19 and flu are at much greater risk of severe disease and death, research shows.
COVID treatment trial
Aspirin may improve 3-month survival for patients critically ill with COVID-19
Antiplatelet drugs such as aspirin have little effect on the need for life support in COVID-19, but they may improve survival in the following months.
COVID breathlessness
Ongoing ‘immune injuries’ might cause persistent breathlessness after COVID-19
Long-lasting immune activity in the airways might be the cause of persistent breathlessness following COVID-19.
LFT accuracy
Lateral flow tests may be missing ‘substantial’ number of COVID-19 infections
Lateral flow tests appear to miss a substantial number of COVID-19 infections, particularly for people without symptoms, experts have warned.
Good genes
A genetic difference affects the likelihood of severe COVID-19 infection
A common genetic change is associated with a reduced risk of severe COVID-19 infection, highlighting a potential target for drugs in early treatment.
